| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05c62f2cf821f016678afe25fbcd6ced |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate |
2008-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bd1bbbfed9432f0ec6f67bc1f40b091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9795c50d3c8f1928743b8e556dd16119
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d311a1c062f12f8265fb7e6463c37efb |
| publicationDate |
2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2009215280-A |
| titleOfInvention |
New HCV entry inhibitor |
| abstract |
Provided is an HCV entry inhibitor which is searched based on a binding inhibition mechanism between CD81 and E2 protein of HCV and has an excellent ability to inhibit HCV entry against HCV proliferation. The general formula (I) Embedded image [Wherein R 1 represents a hydrogen atom or the like. ] A hepatitis C virus entry inhibitor comprising as an active ingredient a hexahydrocyclopentaquinolylamine derivative represented by formula (I) or a physiologically acceptable salt thereof. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012107589-A1 |
| priorityDate |
2008-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |